NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 270 filers reported holding NEKTAR THERAPEUTICS in Q4 2017. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $589,000 | -16.1% | 33,010 | +1.5% | 0.02% | -17.4% |
Q4 2019 | $702,000 | +663.0% | 32,510 | +540.0% | 0.02% | +475.0% |
Q3 2019 | $92,000 | -49.2% | 5,080 | 0.0% | 0.00% | -69.2% |
Q2 2019 | $181,000 | +64.5% | 5,080 | +54.9% | 0.01% | +85.7% |
Q1 2019 | $110,000 | -39.9% | 3,280 | -41.2% | 0.01% | -36.4% |
Q4 2018 | $183,000 | -11.2% | 5,580 | +32.2% | 0.01% | 0.0% |
Q2 2018 | $206,000 | -54.0% | 4,220 | 0.0% | 0.01% | -50.0% |
Q1 2018 | $448,000 | -87.3% | 4,220 | -92.9% | 0.02% | -87.6% |
Q4 2017 | $3,534,000 | +150.3% | 59,170 | +0.6% | 0.18% | +136.0% |
Q3 2017 | $1,412,000 | +96.9% | 58,840 | +60.5% | 0.08% | +108.3% |
Q2 2017 | $717,000 | -12.6% | 36,660 | +5.0% | 0.04% | -7.7% |
Q1 2017 | $820,000 | +94.8% | 34,920 | +1.7% | 0.04% | +95.0% |
Q4 2016 | $421,000 | -19.0% | 34,350 | +13.6% | 0.02% | -25.9% |
Q3 2016 | $520,000 | +22.9% | 30,250 | +1.6% | 0.03% | +17.4% |
Q2 2016 | $423,000 | +6.0% | 29,760 | +2.5% | 0.02% | -14.8% |
Q1 2016 | $399,000 | -11.5% | 29,020 | +8.3% | 0.03% | -18.2% |
Q4 2015 | $451,000 | +56.1% | 26,790 | +1.6% | 0.03% | +200.0% |
Q3 2015 | $289,000 | – | 26,380 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |